Over the last decade-plus, China has become a booming biopharma innovator thanks in part to a big boost from its government. Now the question is, can its neighbor to the south, India, make a similar ...

LAS VEGAS (KLAS) – A possible biological laboratory found at a home in Las Vegas on Saturday may be connected to a similar incident in California, where officials found infectious agents such as HIV ...

Recorded Q4'25 revenue of KRW 1,286 billion and FY'25 revenue of KRW 4,557 billion Maintained momentum through consistent operational performance and robust client demand Strengthened foundation for ...

Bionic Biologics represent a novel therapeutic modality that integrates principles of biologic and synthetic design. This innovative platform enables the targeting of well-validated yet previously ...

There is an epidemic of antidepressant use across the Western world. In England, the number of prescriptions for antidepressants has more than tripled in two decades, and as more people are taking ...

Samsung Biologics, a biotechnology company based in South Korea, announced plans to open its first U.S. manufacturing facility in Rockville, according to Gov. Wes Moore‘s office. Last month, Samsung ...

South Korean pharmaceutical giant Samsung Biologics is making a major acquisition in the D.C. suburbs to establish its first U.S. manufacturing facility. The company reached an agreement to acquire ...

A South Korean biomanufacturing giant is set to purchase its first drug production facility in the U.S. for a sum worthy of its tech giant parent. Samsung Biologics is the world’s largest contract ...

SEOUL, Dec 22 (Reuters) - South Korea's Samsung Biologics (207940.KS), opens new tab said on Monday it is acquiring its first U.S. drug production facility from GSK (GSK.L), opens new tab for $280 ...

(RTTNews) - Samsung Biologics (207940.KS) announced that its wholly owned U.S. subsidiary, Samsung Biologics America, will acquire 100% of Human Genome Sciences from GSK (GSK, GSK.L) for US$280 ...

M arking a significant expansion of the company’s global footprint and long-term commitment to the U.S. market, Samsung Biologics America (SBA) has entered into an agreement with GSK to acquire 100% ...